Abraham NG+ editorial board - Health Sciences Library - New York ...

More documents

Recommendations

Info

Fried B, Reddy A, Mayer D+. Helminths in human carcinogenesis. Cancer Lett 2011 Jun;305(2):239-49. Dept: Surgery PMID: 20667649 DOI: 10.1016/j.canlet.2010.07.008 Friedman DM see Acherman RJ see Buyon JP Friedman E; Koestler J+. Standardized interactive multi-station assessments. In: Levine JL, editor. Guide to medical education in the teaching hospital. 4th ed. Irwin, PA: Association for Hospital Medical Education; 2010. pp. 337-44. Dept: Pediatrics Frishman WH+. Advances in cardiovascular pharmacotherapeutics: online companion to Cardiovascular pharmacotherapeutics - 3rd ed., by William H. Frishman, MD, MACP and Domenic A. Sica, MD, published by Cardiotext Publishing. [Internet]. [cited Nov 3 2011]. Available from: http://cardiovascularpharmacotherapeutics.com Dept: Medicine Frishman WH+. Alpha- and beta-adrenergic blocking drugs. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 57- 85. Dept: Medicine Frishman WH+. Alternative and complementary medicine for preventing and treating cardiovascular disease. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 473-92. Dept: Medicine Frishman WH+. Basic principles of clinical pharmacology relevant to cardiology. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 3-15. Dept: Medicine Frishman WH+. In memoriam: Edmund H. Sonnenblick, MD, 1932-2007. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. xvii-xviii. Dept: Medicine Frishman WH+. Pharmacotherapy for smoking cessation. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 385- 96. Dept: Medicine Frishman WH+, editor. Year Book of Medicine. Philadelphia, PA: Elsevier. Vol. 2010, Dept: Medicine Frishman WH+, editorial board. Am J Hypertens. New York: Nature Publishing Group. Vol. 24, 2011. Dept: Medicine Frishman WH+, supplements editor. Am J Med. New York: Elsevier. Vol. 124, 2011. Dept: Medicine + indicates NYMC faculty 30
Frishman WH+; Arnold RJG. Importance of medication adherence in cardiovascular disease treatment. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 31-8. Dept: Medicine Frishman WH+; Aronow WS+. Lipid-lowering drugs. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 323- 75. Dept: Medicine Frishman WH+; Gewitz MH+. In memoriam: Paul Woolf, MD, 1951-2010. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. xix. Dept: Medicine; Pediatrics Frishman WH+; Glasser SP. The placebo effect in the treatment of cardiovascular disease. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 17-29. Dept: Medicine Frishman WH+; Klapholz M; Oghlakian G; Cook JM. Vasopressin and vasopressin receptor antagonists. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 451-60. Dept: Medicine Frishman WH+; Lerner RG+; Desai HV+. Antiplatelet and other antithrombotic drugs. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 257-304. Dept: Medicine Frishman WH+; Meyer BR. Cholinergic and anticholinergic drugs. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 93-7. Dept: Medicine Frishman WH+; Mogul HR+; Peterson SJ+. Pharmacotherapy of obesity. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 397-412. Dept: Medicine; SHSP Physical Therapy Frishman WH+; Nawarskas JJ; Anderson JR. Ranolazine: a piperazine derivative. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 217-22. Dept: Medicine Frishman WH+,O'Gara PT, co-editors-in-chief. Cardiol Rev. Philadelphia, PA: Lippincott Williams & Wilkins. Vol. 19, 2011. Dept: Medicine Frishman WH+; Palaniswamy C+. Selective and nonselective dopamine-receptor agonists. In: Frishman WH+; Sica DA, editors. Cardiovascular pharmacotherapeutics. 3rd ed. Minneapolis, MN: Cardiotext; 2011. pp. 439-44. Dept: Medicine + indicates NYMC faculty 31
Page 1 and 2: New York Medical College Health Sci
Page 3 and 4: FACULTY AUTHORS’ BIBLIOGRAPHY ©N
Page 5: FACUL TV AUTHORS' BIBLIOGRAPHY July
Page 8 and 9: Ahmed MI, Ekundayo OJ, Mujib M, Cam
Page 10 and 11: Arno PS+ and Viola D+. The Social S
Page 12 and 13: the American College of Cardiology
Page 14 and 15: Avitzur O+. In practice: what to do
Page 16 and 17: Bellner L, Wolstein J, Patil KA, Du
Page 18 and 19: Blumenthal R, Frishman WH+. Super b
Page 20 and 21: Burjonrappa SC+, Youssef S, St-Vil
Page 22 and 23: Cang S, Lu Q, Ma Y, Liu D+. Clinica
Page 24 and 25: Chen LJ, Tam PO, Tham CC, Liang XY,
Page 26 and 27: Clare CA+, Yeh J. Vulvodynia in ado
Page 28 and 29: Darzynkiewicz Z+, editorial board.
Page 30 and 31: De Moraes CG, Liebmann JM+, Susanna
Page 32 and 33: Dunkin JM, Crum AV, Swanger RS+, Bo
Page 34 and 35: Clin Nephrol 2011 Jun;75(6):524-33.
Page 38 and 39: Frishman WH+; Pallerla K. Cardiovas
Page 40 and 41: immunodeficiency (CVID). J Gastroin
Page 42 and 43: Gewitz MH+; Woolf P; Frishman WH+.
Page 44 and 45: Golombek SG+, Truog WE, Ballard RA,
Page 46 and 47: Dept: Psychiatry and Behavioral Sci
Page 48 and 49: Hendin H+, Al Jurdi RK, Houck PR, H
Page 50 and 51: + indicates NYMC faculty 44 see Wu
Page 52 and 53: Jittpoonkuson T, Garcia PMT+, Rosen
Page 54 and 55: Kim BH, Min YS, Choi JS, Baeg GH+,
Page 56 and 57: Kumar A see Jain S Kumar D, Konkima
Page 58 and 59: Lee SH, Baig M, Rusciano V, Dutcher
Page 60 and 61: Lima VC, Yeung L, Castro LC, Landa
Page 62 and 63: Lui YW, Tang ER, Allmendinger AM, S
Page 64 and 65: McCormick SA+, editorial board. Oph
Page 66 and 67: MetLife Mature Market Institute, Na
Page 68 and 69: Nandipati KC, Allamaneni S, Kakarla
Page 70 and 71: Ojaimi C+, Kinugawa S, Recchia FA+,
Page 72 and 73: medical problems including circulat
Page 74 and 75: + indicates NYMC faculty 68 see Lam
Page 76 and 77: Plotkin SA, Wormser GP+, guest edit
Page 78 and 79: Raghunath N, Glassman MS, Halata MS
Page 80 and 81: + indicates NYMC faculty 74 see For
Page 82 and 83: Ryan RM, Brion LP, Aucott SW, Juul
Page 84 and 85: Schwartzman ML see Bellner L see Ki
Page 86 and 87:
Sharma M+, Aronow WS+, Patel L, Gan
Page 88 and 89:
Sinaki B, Jayabose S+, Sandoval C+.
Page 90 and 91:
Stewart JM see Freeman R see Ocon A
Page 92 and 93:
Teune MJ, van Wassenaer AG+, Mol BW
Page 94 and 95:
Ungvari Z, Bagi Z+, Feher A, Recchi
Page 96 and 97:
Dept: Family and Community Medicine
Page 98 and 99:
ack-pain-part-3-52389.html Dept: Co
Page 100 and 101:
Wlodkowic D, Darzynkiewicz Z+. Rise
Page 102 and 103:
Epidemiology and clinical practice.
Page 104 and 105:
endothelial progenitors: Exchange o
Page 106 and 107:
Zia MT see Chua CO see Haleem A see
Page 108 and 109:
http://f1000.com/4502959#evaluation
Page 110 and 111:
Kaplan JG+. Are we prepared to care
Page 112 and 113:
Interest-in-Medicine Dept: Pediatri
Page 114 and 115:
Lowenfels AB+. Viewpoints: Does pre
Page 116 and 117:
Lowenfels AB+. Viewpoints: Platelet
Page 118 and 119:
McGoldrick KE+. Comment: A prospect
Page 120 and 121:
Anesthesiol 2011 Feb;55(1):55. Dept
Page 122 and 123:
McGoldrick KE+. Comment: Osteonecro
Page 124 and 125:
et al. in Anesth Analg 111:432-6, 2
Page 126 and 127:
PART III Departmental Listing A. Sc
Page 128 and 129:
Schaefer SD Schantz SP Sclafani AP
Page 130:
124
show all

Abraham NG+ editorial board - Health Sciences Library - New York ...

Create successful ePaper yourself

Delete template?

Save as template?